Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 2Urinary Bladder Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Pancreatic Cancer Metastatic 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1Advanced Renal Cell Carcinoma (RCC) 1Advanced Malignant Solid Tumors 1Advanced Lung Cancer 1Advanced Breast Cancer 1

Interventions

Cisplatin 5Gemcitabine 4Oxaliplatin 2Irinotecan 2Fluorouracil 2Capecitabine 2Bevacizumab 2zanidatamab 1toripalimab 1pembrolizumab 1niraparib 1neratinib 1ivosidenib 1futibatinib 1fludarabine 1envafolimab 1encorafenib 1durvalumab 1binimetinib 1Trastuzumab 1Pemetrexed 1Nivolumab 1Folfox protocol 1Docetaxel 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Actigraphy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × toripalimab × 30 days × Clear all
NCT07619235 2026-06-01

A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer

Huazhong University of Science and Technology

Phase 4 Not yet recruiting
32 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡